Better-educated middle-aged Americans are less likely to smoke and more apt to be physically active than their less-educated peers. They also are more inclined to make healthy changes and adhere to them, according to a new study in the September issue of the Journal of Health and Social Behavior.
The American Lung Association in Virginia and Anthem Blue Cross Blue Shield are supporting smokers in Richmond, Va., in their efforts to quit for good through the “Quitter in You” smoking-cessation campaign, the companies announced Friday.
The study, supported by NJoy and led by independent researchers Mitchell Nides, Ph.D., and Scott Leischow, Ph.D., evaluated nicotine delivery from the NJoy Kings Bold Electronic Delivery System and its short-term potential for smoking reduction or cessation.
Even though section 1201 of the Patient Protection and Affordable Care Act — the section that enables health payers to charge a 50% premium on smokers — won't go into effect until 2015, smoking cessation will be a growing category in 2014.
The Food and Drug Administration is allowing the marketing of two new tobacco products under regulations that allow tobacco companies to market products if they can prove they are similar enough to ones already on the market.
States that want to reduce rates of adult smoking may consider implementing stringent tobacco restrictions on teens, suggested a new study released by researchers at Washington University School of Medicine in St. Louis on Thursday.
Researchers from the Perelman School of Medicine at the University of Pennsylvania last week reported that an area of the brain that initiates behavioral changes had greater activation in smokers who watched anti-smoking ads with strong arguments versus those with weaker ones, and irrespective of such flashy elements as bright and rapidly changing scenes, loud sounds and unexpected scenario twists.
A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.
GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.
In spite of a court ruling striking down a ban on large-sized sugary drinks, New York mayor Michael Bloomberg has another health initiative in the works: a requirement that retailers hide tobacco products.